Antibody response to human parvovirus B19 in patients with primary infection by immunoblot assay with recombinant proteins

Clinical and Diagnostic Laboratory Immunology

Volumn 3, Issue 2, 1996, Pages 236-238

  Palmer, P ^a,c   Pallier, C ^a   Leruez Ville, M ^b   Deplanche, M ^a   Morinet, F ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b AVICENNE HOSPITAL   (France)

^c HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RECOMBINANT PROTEIN; VIRUS ANTIBODY; VIRUS ANTIGEN;

ADULT; ANTIBODY RESPONSE; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOBLOTTING; MALE; PARVOVIRUS; PRIORITY JOURNAL; SEROCONVERSION; VIRUS INFECTION;

EID: 0029913652     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.3.2.236-238.1996     Document Type: Article

References (15)

1. Anderson, M. J., P. G. Higgins, L. R. Davis, S. J. Williams, S. E.Jones, I. M. Kidd, J. R. Pattison, and D. A. J. Tyrrell. 1985. Experimental parvoviral infection in humans. J. Infect. Dis. 152:257-265.
2. Bansal, G. P., J. A. Hatfield, F. E. Dunn, A. A. Kramer, F. Brady, C. H. Riggin, M. S. Collett, K. Yoshimoto, S. Kajigaya, and N. S. Young. 1993. Candidate recombinant vaccine for human B19 parvovirus. J. Infect. Dis. 167:1034-1044.
3. Belloy, M., F. Morinet, G. Blondin, A. M. Courouce, Y. Perol, and E. Vilmer. 1990. Erythroid hypoplasia due to chronic infection with parvovirus B19. N. Engl. J. Med. 322:633-634.
4. Cohen, B. J., P. P. Mortimer, and S. M. Pereira. 1983. Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J. Hyg. Camb. 91:113-130.
5. Couroucé, A. M., F. Ferchal, F. Morinet, A. Muller, J. Drouet, J. P. Soulier, and Y. Perol. 1984. Human parvovirus infections in France. Lancet i:160.
6. Gray, J. J., B. J. Cohen, and U. Desselberger. 1993. Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity. J. Virol. Methods 44:11-24.
7. Kurtzman, G. J., B. J. Cohen, A. M. Field, R. Oseas, R. M. Blaese, and N. S. Young. 1989. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J. Clin. Invest. 84:1114-1123.
8. Leruez, M., C. Pallier, I. Vassias, J. P. Elouet, P. Romeo, and F. Morinet. 1994. Differential transcription, without replication, of non-structural and structural genes of human parvovirus B19 in UT7/EPO cell line as demonstrated by in situ hybridization. J. Gen. Virol. 75:1475-1478.
9. Ozawa, K., J. Ayub, and N. S. Young. 1988. Translational regulation of B19 parvovirus capsid protein production by multiple upstream AUG triplets. J. Biol. Chem. 263:10922-10926.
10. Rosenfeld, S. J., K. Yoshimoto, S. Kajigaya, A. Anderson, N. S. Young, A. Field, P. Warrener, G. Bansal, and M. S. Collett. 1992. Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. J. Clin. Invest. 89:2023-2029.
11. Sato, H., J. Hirata, M. Furukawa, N. Kuroda, H. Shiraki, Y. Maeda, and K. Okochi. 1991. Identification of the region including the epitope for a monoclonal antibody which can neutralize human parvovirus B19. J. Virol. 65:1667-1672.
12. Schwartz, T. F., M. Roggendorf, and F. Deinhardt. 1988. Human parvovirus B19: ELISA and immunoblot assays. J. Virol. Methods 20:155-168.
13. Shade, R. O., M. C. Blundell, S. F. Cotmore, P. Tattersall, and C. R. Astell. 1986. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J. Virol. 58:921-936.
14. Smith, D. B., and K. S. Johnson. 1988. Single-step purification of polypeptides expressed in Eschcrichia coli as fusions with glutathione S-transferase. Gene 67:31-40.
15. Söderlund, M., C. S. Brown, W. J. M. Spaan, L. Hedman, and K. Hedman. 1995. Epitope type specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19: a new diagnostic concept. In Program and abstracts of the VIth Parvovirus Workshop. Centre National de la Recherche Scientifique, Montpellier, France.